Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Comment by RamboOO7on Jul 08, 2021 7:24pm
163 Views
Post# 33519192

RE:THC Biomed announced Q3 revenue of $1.1M, up 24% YoY.

RE:THC Biomed announced Q3 revenue of $1.1M, up 24% YoY.I knew the numbers were unrealistic. How could that a$$hole CEO post that in their website knowing numbers would be way off
Investorsnews wrote: THC BioMed Intl Ltd. (CSE: THC / OTC: THCBF / FSE: TFHC)  announced Q3 revenue of $1.1M, up 24% YoY. Although Q3 revenue increased QoQ and YoY, it was below our expectations due to lower than expected sales of dried flowers and edibles. We will be publishing an update shortly.
 
Would you like to get more ideas from our analysts' team? Read our Analysts' Ideas of the week: https://www.researchfrc.com/positive-developments-for-psychedelics-and-medical-cannabis/
 
 
*FRC provides issuer paid coverage.
*Past performance is not indicative of future results.



<< Previous
Bullboard Posts
Next >>